Top

Published in:

Open Access 01-12-2014 | Research

MotorPlex provides accurate variant detection across large muscle genes both in single myopathic patients and in pools of DNA samples

Authors: Marco Savarese, Giuseppina Di Fruscio, Margherita Mutarelli, Annalaura Torella, Francesca Magri, Filippo Maria Santorelli, Giacomo Pietro Comi, Claudio Bruno, Vincenzo Nigro

Published in: Acta Neuropathologica Communications | Issue 1/2014

Abstract

Mutations in ~100 genes cause muscle diseases with complex and often unexplained genotype/phenotype correlations. Next-generation sequencing studies identify a greater-than-expected number of genetic variations in the human genome. This suggests that existing clinical monogenic testing systematically miss very relevant information.

We have created a core panel of genes that cause all known forms of nonsyndromic muscle disorders (MotorPlex). It comprises 93 loci, among which are the largest and most complex human genes, such as TTN, RYR1, NEB and DMD. MotorPlex captures at least 99.2% of 2,544 exons with a very accurate and uniform coverage. This quality is highlighted by the discovery of 20-30% more variations in comparison with whole exome sequencing. The coverage homogeneity has also made feasible to apply a cost-effective pooled sequencing strategy while maintaining optimal sensitivity and specificity.

We studied 177 unresolved cases of myopathies for which the best candidate genes were previously excluded. We have identified known pathogenic variants in 52 patients and potential causative ones in further 56 patients. We have also discovered 23 patients showing multiple true disease-associated variants suggesting complex inheritance. Moreover, we frequently detected other nonsynonymous variants of unknown significance in the largest muscle genes. Cost-effective combinatorial pools of DNA samples were similarly accurate (97-99%).

MotorPlex is a very robust platform that overcomes for power, costs, speed, sensitivity and specificity the gene-by-gene strategy. The applicability of pooling makes this tool affordable for the screening of genetic variability of muscle genes also in a larger population. We consider that our strategy can have much broader applications.

Available only for authorised users

Kaplan JC, Hamroun D: The 2014 version of the gene table of monogenic neuromuscular disorders (nuclear genome). Neuromuscul Disord 2013, 23: 1081–1111. 10.1016/j.nmd.2013.10.006CrossRefPubMed

Nigro V, Savarese M: Genetic basis of limb-girdle muscular dystrophies: the 2014 update. Acta Myol 2014, 33: 1–12.PubMedPubMedCentral

Nigro V, Aurino S, Piluso G: Limb girdle muscular dystrophies: update on genetic diagnosis and therapeutic approaches. Curr Opin Neurol 2011, 24: 429–436. doi: 10.1097/WCO.0b013e32834aa38d 10.1097/WCO.0b013e32834aa38dCrossRefPubMed

Mercuri E, Muntoni F: Muscular dystrophies. Lancet 2013, 381: 845–860. doi: 10.1016/S0140–6736(12)61897–2 10.1016/S0140-6736(12)61897-2CrossRefPubMed

Leung DG, Wagner KR: Therapeutic advances in muscular dystrophy. Ann Neurol 2013, 74: 404–411.CrossRefPubMedPubMedCentral

Sacconi S, Lemmers RJ, Balog J, van der Vliet PJ, Lahaut P, van Nieuwenhuizen MP, Straasheijm KR, Debipersad RD, Vos-Versteeg M, Salviati L, Casarin A, Pegoraro E, Tawil R, Bakker E, Tapscott SJ, Desnuelle C, van der Maarel SM: The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1. Am J Hum Genet 2013, 93: 744–751. doi: 10.1016/j.ajhg.2013.08.004 10.1016/j.ajhg.2013.08.004CrossRefPubMedPubMedCentral

Nigro V, Piluso G: Next generation sequencing (NGS) strategies for the genetic testing of myopathies. Acta Myol 2012, 31: 196–200.PubMedPubMedCentral

Metzker ML: Sequencing technologies - the next generation. Nat Rev Genet 2009, 11: 31–46. 10.1038/nrg2626CrossRefPubMed

Yu Y, Wu BL, Wu J, Shen Y: Exome and whole-genome sequencing as clinical tests: a transformative practice in molecular diagnostics. Clin Chem 2012, 58: 1507–1509. 10.1373/clinchem.2012.193128CrossRefPubMed

10.

Beaulieu CL, Majewski J, Schwartzentruber J, Samuels ME, Fernandez BA, Bernier FP, Brudno M, Knoppers B, Marcadier J, Dyment D, Adam S, Bulman DE, Jones SJ, Avard D, Nguyen MT, Rousseau F, Marshall C, Wintle RF, Shen Y, Scherer SW, Canada Consortium FORGE, Friedman JM, Michaud JL, Boycott KM: FORGE Canada Consortium: outcomes of a 2-year national rare-disease gene-discovery project. Am J Hum Genet 2014, 94: 809–817. doi: 10.1016/j.ajhg.2014.05.003 10.1016/j.ajhg.2014.05.003CrossRefPubMedPubMedCentral

11.

Gilissen C, Hoischen A, Brunner HG, Veltman JA: Disease gene identification strategies for exome sequencing. Eur J Hum Genet 2012, 20: 490–497. doi: 10.1038/ejhg.2011.258 10.1038/ejhg.2011.258CrossRefPubMedPubMedCentral

12.

Roscioli T, Kamsteeg EJ, Buysse K, Maystadt I, van Reeuwijk J, van den Elzen C, van Beusekom E, Riemersma M, Pfundt R, Vissers LE, Schraders M, Altunoglu U, Buckley MF, Brunner HG, Grisart B, Zhou H, Veltman JA, Gilissen C, Mancini GM, Delrée P, Willemsen MA, Ramadža DP, Chitayat D, Bennett C, Sheridan E, Peeters EA, Tan-Sindhunata GM, de Die-Smulders CE, Devriendt K, Kayserili H, El-Hashash OA: Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of alpha-dystroglycan. Nat Genet 2012, 44: 581–585. doi: 10.1038/ng.2253 10.1038/ng.2253CrossRefPubMedPubMedCentral

13.

Torella A, Fanin M, Mutarelli M, Peterle E, Del Vecchio Blanco F, Rispoli R, Savarese M, Garofalo A, Piluso G, Morandi L, Ricci G, Siciliano G, Angelini C, Nigro V: Next-generation sequencing identifies transportin 3 as the causative gene for LGMD1F. PLoS One 2013, 8: e63536. doi: 10.1371/journal.pone.0063536 PONE-D-13–06808 10.1371/journal.pone.0063536CrossRefPubMedPubMedCentral

14.

Harms MB, Sommerville RB, Allred P, Bell S, Ma D, Cooper P, Lopate G, Pestronk A, Weihl CC, Baloh RH: Exome sequencing reveals DNAJB6 mutations in dominantly-inherited myopathy. Ann Neurol 2012, 71: 407–416. doi: 10.1002/ana.22683 10.1002/ana.22683CrossRefPubMedPubMedCentral

15.

Johnston JJ, Rubinstein WS, Facio FM, Ng D, Singh LN, Teer JK, Mullikin JC, Biesecker LG: Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes. Am J Hum Genet 2012, 91: 97–108. 10.1016/j.ajhg.2012.05.021CrossRefPubMedPubMedCentral

16.

Rehm HL, Bale SJ, Bayrak-Toydemir P, Berg JS, Brown KK, Deignan JL, Friez MJ, Funke BH, Hegde MR, Lyon E: ACMG clinical laboratory standards for next-generation sequencing. Genet Med 2013, 15: 733–747. doi: 10.1038/gim.2013.92 10.1038/gim.2013.92CrossRefPubMedPubMedCentral

17.

Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, Braxton A, Beuten J, Xia F, Niu Z, Hardison M, Person R, Bekheirnia MR, Leduc MS, Kirby A, Pham P, Scull J, Wang M, Ding Y, Plon SE, Lupski JR, Beaudet AL, Gibbs RA, Eng CM: Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med 2013, 369: 1502–1511. doi: 10.1056/NEJMoa1306555 10.1056/NEJMoa1306555CrossRefPubMedPubMedCentral

18.

Rehm HL: Disease-targeted sequencing: a cornerstone in the clinic. Nat Rev Genet 2013, 14: 295–300. 10.1038/nrg3463CrossRefPubMedPubMedCentral

19.

Berglund EC, Lindqvist CM, Hayat S, Övernäs E, Henriksson N, Nordlund J, Wahlberg P, Forestier E, Lönnerholm G, Syvänen AC: Accurate detection of subclonal single nucleotide variants in whole genome amplified and pooled cancer samples using HaloPlex target enrichment. BMC Genomics 2013, 14: 856. doi: 10.1186/1471–2164–14–856 10.1186/1471-2164-14-856CrossRefPubMedPubMedCentral

20.

Desai AN, Jere A: Next-generation sequencing: ready for the clinics? Clin Genet 2012, 81: 503–510. doi: 10.1111/j.1399–0004.2012.01865.x 10.1111/j.1399-0004.2012.01865.xCrossRefPubMed

21.

Mutarelli M, Marwah VS, R R, Carrella D, Dharmalingam G, Oliva G, di Bernardo D (2014) A community-based resource for automatic exome variant-calling and annotation in Mendelian disorders. BMC Genomics 15: doi: 10.1186/1471–2164–15-s3-s5

22.

Li H, Durbin R: Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009, 25: 1754–1760. 10.1093/bioinformatics/btp324CrossRefPubMedPubMedCentral

23.

DePristo MA, Banks E, Poplin R, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, McKenna A, Fennell TJ, Kernytsky AM, Sivachenko AY, Cibulskis K, Gabriel SB, Altshuler D, Daly MJ: A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 2011, 43: 491–498. 10.1038/ng.806CrossRefPubMedPubMedCentral

24.

Wang K, Li M, Hakonarson H: ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010, 38: e164. 10.1093/nar/gkq603CrossRefPubMedPubMedCentral

25.

Pruitt KD, Tatusova T, Brown GR, Maglott DR: NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy. Nucleic Acids Res 2012, 40: D130–135. 10.1093/nar/gkr1079CrossRefPubMed

26.

Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K: dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001, 29: 308–311. 10.1093/nar/29.1.308CrossRefPubMedPubMedCentral

27.

Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, Hurles ME, McVean GA: A map of human genome variation from population-scale sequencing. Nature 2010, 467: 1061–1073. 10.1038/nature09534CrossRefPubMed

28.

Pollard KS, Hubisz MJ, Rosenbloom KR, Siepel A: Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res 2010, 20: 110–121. 10.1101/gr.097857.109CrossRefPubMedPubMedCentral

29.

Goode DL, Cooper GM, Schmutz J, Dickson M, Gonzales E, Tsai M, Karra K, Davydov E, Batzoglou S, Myers RM, Sidow A: Evolutionary constraint facilitates interpretation of genetic variation in resequenced human genomes. Genome Res 2010, 20: 301–310. 10.1101/gr.102210.109CrossRefPubMedPubMedCentral

30.

Liu X, Jian X, Boerwinkle E: dbNSFP: a lightweight database of human nonsynonymous SNPs and their functional predictions. Hum Mutat 2011, 32: 894–899. 10.1002/humu.21517CrossRefPubMedPubMedCentral

31.

Schwarz JM, Rodelsperger C, Schuelke M, Seelow D: MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 2010, 7: 575–576. 10.1038/nmeth0810-575CrossRefPubMed

32.

Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet, Chapter 7: Unit7 20

33.

Kumar P, Henikoff S, Ng PC: Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009, 4: 1073–1081. 10.1038/nprot.2009.86CrossRefPubMed

34.

Thorvaldsdottir H, Robinson JT, Mesirov JP: Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 2012, 14: 178–192. 10.1093/bib/bbs017CrossRefPubMedPubMedCentral

35.

Laing NG: Genetics of neuromuscular disorders. Crit Rev Clin Lab Sci 2012, 49: 33–48. 10.3109/10408363.2012.658906CrossRefPubMed

36.

Cirak S, Foley AR, Herrmann R, Willer T, Yau S, Stevens E, Torelli S, Brodd L, Kamynina A, Vondracek P, Roper H, Longman C, Korinthenberg R, Marrosu G, Nürnberg P, Michele DE, Plagnol V, Hurles M, Moore SA, Sewry CA, Campbell KP, Voit T, Muntoni F: ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies. Brain 2013, 136: 269–281. doi: 10.1093/brain/aws312 10.1093/brain/aws312CrossRefPubMedPubMedCentral

37.

Logan CV, Lucke B, Pottinger C, Abdelhamed ZA, Parry DA, Szymanska K, Diggle CP, van Riesen A, Morgan JE, Markham G, Ellis I, Manzur AY, Markham AF, Shires M, Helliwell T, Scoto M, Hübner C, Bonthron DT, Taylor GR, Sheridan E, Muntoni F, Carr IM, Schuelke M, Johnson CA: Mutations in MEGF10, a regulator of satellite cell myogenesis, cause early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD). Nat Genet 2011, 43: 1189–1192. doi: 10.1038/ng.995 10.1038/ng.995CrossRefPubMed

38.

Sarparanta J, Jonson PH, Golzio C, Sandell S, Luque H, Screen M, McDonald K, Stajich JM, Mahjneh I, Vihola A, Raheem O, Penttilä S, Lehtinen S, Huovinen S, Palmio J, Tasca G, Ricci E, Hackman P, Hauser M, Katsanis N, Udd B: Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy. Nat Genet 2012, 44: 450–455. S451–452, doi: 10.1038/ng.1103 10.1038/ng.1103CrossRefPubMedPubMedCentral

39.

Vasli N, Böhm J, Le Gras S, Muller J, Pizot C, Jost B, Echaniz-Laguna A, Laugel V, Tranchant C, Bernard R, Plewniak F, Vicaire S, Levy N, Chelly J, Mandel JL, Biancalana V, Laporte J: Next generation sequencing for molecular diagnosis of neuromuscular diseases. Acta Neuropathol 2012, 124: 273–283. doi: 10.1007/s00401–012–0982–8 10.1007/s00401-012-0982-8CrossRefPubMedPubMedCentral

40.

Chen X, Listman JB, Slack FJ, Gelernter J, Zhao H: Biases and errors on allele frequency estimation and disease association tests of next-generation sequencing of pooled samples. Genet Epidemiol 2012, 36: 549–560. doi: 10.1002/gepi.21648 10.1002/gepi.21648CrossRefPubMedPubMedCentral

Title: MotorPlex provides accurate variant detection across large muscle genes both in single myopathic patients and in pools of DNA samples
Authors: Marco Savarese
Giuseppina Di Fruscio
Margherita Mutarelli
Annalaura Torella
Francesca Magri
Filippo Maria Santorelli
Giacomo Pietro Comi
Claudio Bruno
Vincenzo Nigro
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: Acta Neuropathologica Communications / Issue 1/2014
Electronic ISSN: 2051-5960
DOI: https://doi.org/10.1186/s40478-014-0100-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

MotorPlex provides accurate variant detection across large muscle genes both in single myopathic patients and in pools of DNA samples

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

Evidence for mTOR pathway activation in a spectrum of epilepsy-associated pathologies

The identification of mitochondrial DNA variants in glioblastoma multiforme

Immunoreactivity of valosin-containing protein in sporadic amyotrophic lateral sclerosis and in a case of its novel mutant

Ischemia induces different levels of hypoxia inducible factor-1α protein expression in interneurons and pyramidal neurons

A neuronal function of the tumor suppressor protein merlin

Tau accumulation in the nucleus accumbens in tangle-predominant dementia